The grim statistics is what keep scientists like Anja Brau motivated. “Cardiovascular disease isn’t just a European issue, it’s a human issue,” says Brau, director of global cardiac magnetic resonance at GE Healthcare. GE Healthcare and Arterys, a privately held company specializing in cloud based intelligent medical imaging, have been quietly working in partnership together to deliver an end-to-end solution that radically changes how the heart is imaged by MRI and then analyzed automatically in the cloud. The partnership was announced at this year’s RSNA conference.
Their technology, ViosWorks* can do the job in 10 to 15 minutes, rather than the more typical 45 minutes to an hour. It displays the results in 7 dimensions - 3 in space, 1 in time, and 3 in velocity direction - showing the actual blood flow in the heart as a moving image.
GE Healthcare and Arterys brought the technology to this year's meeting of the Radiological Society of North America (RSNA), which is taking place this week in Chicago. RSNA is the world's largest gathering of radiologists, drawing an expected 60,000 visitors.
ViosWorks* can help physicians distinguish scarred or damaged tissue from healthy heart muscle and tell them whether blood is flowing through the heart the way it should be.
Every second counts. Doctors need to assess damage as quickly as possible to administer the right treatment, prevent death, speed recovery and reduce healthcare costs. The CDC Foundation estimates that by 2030, annual direct medical costs associated with cardiovascular diseases will rise to more than $818 billion, while lost productivity costs could exceed $275 billion. For comparison, the U.S., which has the world’s largest defense budget, spends on the military about $600 billion annually.
But it’s not so easy. MRI works by “acquiring” the image of the organ one thin slice of tissue after another – kind of like rebuilding a salami stick from individual slices. However, the procedure can take up to an hour and patients have to remain still. This is doubly difficult when imaging body parts like the heart, which keeps moving.
Says Brau: “As exciting and encouraging as these breakthroughs are, they are also just the beginning of what we can achieve.”
*Not yet commercially available